Day: February 20, 2024

COPENHAGEN, Denmark, Feb. 20, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces the successful completion of the initial phases of its vaccine collaboration with MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA). The vaccine development project combines both organizations’ unique capabilities and know-how. Evaxion’s Chief Executive Officer Christian Kanstrup expresses enthusiasm, “In September last year, we announced a collaboration with a leading pharma company, and today we are proud to present that this collaborator is MSD. Further, we are excited about the successful conclusion of the vaccine target discovery and design phases...

ORALTO Phase 3 trial focused on desired initial target indication of early oral step-down treatment of invasive aspergillosis infections in adults who have limited or no treatment options Non-inferiority trial will enroll approximately 216 patients with primary endpoint of all-cause mortality at day 42 Key secondary endpoint includes superiority of oral step-down treatment with MAT2203 vs. AmBisome® (liposomal amphotericin B) for treatment-related toxicities leading to changes in treatment BEDMINSTER, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces alignment with the U.S. Food and Drug Administration (FDA) on the design of a single Phase...

TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Monday, April 1, 2024. Management will host a conference call at 8:00 a.m. Eastern Time on April 1, 2024 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13744647. A live webcast of the call will also be provided on the investor relations section of the Company’s website at ir.venusconcept.com. For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853...

MONTREAL, Feb. 20, 2024 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the election of Simon Lussier as Director of the Company at the annual meeting of shareholders held on February 15, 2024. “It is a privilege to have Simon join our team. His strategic experience and in depth knowledge of capital markets acquired while working at Sprott Securities as well as his entrepreneurial leadership in financing projects in growth companies makes him a perfect fit for our Board. We are thrilled to benefit from his knowledge and skill set in the years to come,” commented Gino Roger, President and CEO. About Simon Lussier Mr. Lussier holds a bachelor’s degree in commerce and entrepreneurship from McGill University and an MBA in finance from HEC Montréal. He has more than 35 years of diverse...

WILMINGTON, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced its participation in the following investor conference: Raymond James 2024 Annual Institutional Investor ConferencePresentation: Wednesday, March 6, 2024 at 9:15 a.m. ET The live webcast, as well as a replay from the event, will be available on the Company’s Investor relations website at https://investor.ncino.com/news-events/events-and-presentations. About nCinonCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. Through its single software-as-a-service (SaaS) platform, nCino helps financial institutions serving corporate and commercial, small business, consumer, and mortgage customers modernize and more effectively onboard clients, make loans, manage the...

MIGDAL HAEMEK, Israel, February 20, 2024 – Tower Semiconductor (NASDAQ/ TASE: TSEM), the leading foundry of high-value analog semiconductor solutions, today announced that its President, Dr. Marco Racanelli, will attend the Susquehanna Technology Conference on Thursday, February 29, 2024. The conference will take place at the Lotte New York Palace Hotel in New York. At the conference, there will be an opportunity for investors to meet one-on-one with management. Interested investors should contact the conference organizers or email the investor relations team at towersemi@kcsa.com.About Tower Semiconductor          Tower Semiconductor Ltd. (NASDAQ/TASE: TSEM), the leading foundry of high-value analog semiconductor solutions, provides technology, development, and process platforms for integrated circuits (ICs) in growing markets such...